Last reviewed · How we verify
Adept
At a glance
| Generic name | Adept |
|---|---|
| Sponsor | University Hospital, Gasthuisberg |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Anhedonia, Development, and Emotions: Phenotyping and Therapeutics (PHASE4)
- Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial (NA)
- An Adaptive Prenatal Intervention to Increase Childhood Vaccinations (NA)
- Attenuating DEPression With Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU) (NA)
- A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (PHASE2)
- Quantitation of Glymphatic Functioning in Sleep and Meditative States (NA)
- PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery
- rTMS for Military TBI-related Depression (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adept CI brief — competitive landscape report
- Adept updates RSS · CI watch RSS
- University Hospital, Gasthuisberg portfolio CI